Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.43+0.07 (+2.97%)
Close on Nov 18, 2026Market cap $309.52MP/E –Yield –
Nautilus Biotechnology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $234.00K | – |
| Q2 FY2026 | Jun 30, 2026 | $190.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
See a number that looks wrong?